shRNA against CD44 inhibits cell proliferation, invasion and migration, and promotes apoptosis of colon carcinoma cells

Oncology Reports

Volumn 27, Issue 2, 2012, Pages 339-346

  Park, Yeon Sun ^a   Huh, Jung Wook ^a   Lee, Jae Hyuk ^a   Kim, Hyeong Rok ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

CD44; Colon cancer; Short hairpin RNA

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BETA CATENIN; CASPASE 3; CASPASE 8; CASPASE 9; GLYCOGEN SYNTHASE KINASE 3BETA; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; RETROVIRUS VECTOR; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR FKHR; WNT PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CANCER INVASION; CARCINOMA CELL; CD44 GENE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL MIGRATION; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE TEST; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ANTIGENS, CD44; APOPTOSIS; BETA CATENIN; CARCINOMA; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; HUMANS; NEOPLASM INVASIVENESS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RNA, SMALL INTERFERING; TRANSFECTION; WNT1 PROTEIN;

EID: 84862933195     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1532     Document Type: Article

References (50)

1. Grady WM and Carethers JM: Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135: 1079-1099, 2008.
2. Cichy J and Pure E: The liberation of CD44: J Cell Biol 161: 839-843, 2003.
3. Nakamura H, Suenaga N, Taniwaki, et al: Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase. Cancer Res 64: 876-882, 2004. (Pubitemid 38176887)
4. Bourguignon LY: CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. J Mammary Gland Biol Neoplasia 6: 287-297, 2001.
5. Gotte M and Yip GW: Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective. Cancer Res 66: 10233-10237, 2006. (Pubitemid 44799736)
6. Kurozumi K, Nakao K, Nishida T, et al: Significance of biologic aggressiveness and proliferating activity in papillary thyroid carcinoma. World J Surg 22: 1237-1242, 1998. (Pubitemid 28514343)
7. Bankfalvi A, Terpe HJ, Breukelmann D, et al : Immuno phenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44. Histopathology 34: 25-34, 1999. (Pubitemid 29049073)
8. Takahashi K, Stamenkovic I, Cutler M, et al: CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas. Oncogene 11: 2223-2232, 1995. (Pubitemid 26008398)
9. Shtivelman E and Bishop JM: Expression of CD44 is repressed in neuroblastoma cells. Mol Cell Biol 11: 5446-5453, 1991. (Pubitemid 21895309)
10. Ponta H, Sherman L and Herrlich PA: CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4: 33-45, 2003. (Pubitemid 36077255)
11. Johnson P, Maiti A, Brown KL and Li R: A role for the cell adhesion molecule CD44 and sulfation in leukocyte-endothelial cell adhesion during an inflammatory response? Biochem Pharmacol 59: 455-465, 2000. (Pubitemid 30045583)
12. Liu S, Dontu G, Mantle ID, et al: Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66: 6063-6071, 2006.
13. Lowry WE, Blanpain C, Nowak JA, et al: Defining the impact of beta-catenin/Tcf transactivation on epithelial stem cells. Genes Dev 19: 1596-1611, 2005. (Pubitemid 41003002)
14. Reynolds AB and Roczniak-Ferguson A: Emerging roles for p120-catenin in cell adhesion and cancer. Oncogene 23: 7947-7956, 2004. (Pubitemid 39468853)
15. Logan CY and Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810, 2004. (Pubitemid 39488658)
16. Iba T, Kigawa J, Kanamori Y, et al: Expression of the c-myc gene as a predictor of chemotherapy response and a prognostic factor in patients with ovarian cancer. Cancer Sci 95: 418-423, 2004. (Pubitemid 38832685)
17. Peifer M: Beta-catenin as oncogene: the smoking gun. Science 275: 1752-1753, 1997.
18. Gilley J, Coffer PJ and Ham J: FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 162: 613-622, 2003. (Pubitemid 37022939)
19. Dijkers PF, Medema RH, Lammers JW, et al: Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 10: 1201-1204, 2000.
20. Brunet A, Bonni A, Zigmond MJ et al: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868, 1999. (Pubitemid 29165088)
21. Medema RH, Kops GJ, Bos JL and Burgering BM: AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404: 782-787, 2000. (Pubitemid 30212408)
22. Dijkers PF, Medema RH, Pals C, et al: Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol Cell Biol 20: 9138-9148, 2000. (Pubitemid 32246103)
23. Ramaswamy S, Nakamura N, Sansal I, et al: A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2: 81-91, 2002. (Pubitemid 41043990)
24. Schmidt M, Fernandez de Mattos S, van der Horst A, et al: Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol Cell Biol 22: 7842-7852, 2002. (Pubitemid 35217295)
25. Greer E and Brunet A: FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24: 7410-7425, 2005. (Pubitemid 41637981)
26. Brownawell AM, Kops GJ, Macara IG and Burgering BM: Inhibition of nuclear import by protein kinase B(Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol Cell Biol 21: 3534-3546, 2001. (Pubitemid 32381789)
27. Zhao X, Gan L, Pan H, et al: Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation- and 14-3-3-dependent and -independent mechanisms. Biochem J 378: 839-849, 2004. (Pubitemid 38406861)
28. Alessi DR, Andjelkovic M, Caudwell B, et al: Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15: 6541-6551, 1996. (Pubitemid 26413787)
29. Sarbassov DD, Guertin DA, Ali SM and Sabatini DM: Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101, 2005. (Pubitemid 40262113)
30. Farrow SN and Brown R: New members of the Bcl-2 family and their protein partners. Curr Opin Genet Dev 6: 45-49, 1996.
31. Pathan N, Marusawa H, Krajewska, et al: TUCAN, an antiapoptotic caspase-associated recruitment domain family protein overexpressed in cancer. J Biol Chem 276: 32220-32229, 2001.
32. Mielgo A, van Driel M, Bloem A, et al: A novel antiapoptotic mechanism based on interference of Fas signaling by CD44 variant isoforms. Cell Death Differ 13: 465-477, 2006.
33. Rui W, Xi W, Fang L, et al: shRNA-targeted cyclooxygenase (COX)-2 inhibits proliferation, reduces invasion and enhances chemosensitivity in laryngeal carcinoma cells. Mol Cell Biochem 317: 179-188, 2008.
34. Suniti M, Vincent CH, Carla DG, et al: Delivery of CD44 shRNA/Naboparticles within cancer cells. J Biol Chem 284: 12432-12446, 2009.
35. Weber GF, Bronson RT, Ilagan J, et al: Absence of the CD44 gene prevents sarcoma metastasis. Cancer Res 62: 2281-2286, 2002. (Pubitemid 34411705)
36. Elbashir SM, Harborth J, Lendeckel W, et al: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498, 2002.
37. Paddison PJ, Caudy AA, Bernstein E, et al: Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 16: 948-958, 2002. (Pubitemid 34408544)
38. Clevers H: Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480, 2006.
39. Hall CL and Keller ET: The role of Wnts in bone metastases. Cancer Metastasis Rev 25: 551-558, 2006. (Pubitemid 46074998)
40. Tetsu O and McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422-426, 1999. (Pubitemid 29180374)
41. Hall CL, Bafico A, Dai J, et al: Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Res 65: 7554-7560, 2005. (Pubitemid 41297224)
42. Mao B, Wu W, Davidson G, et al: Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 417: 664-667, 2002. (Pubitemid 34614827)
43. + slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis. Cancer Sci 101: 673-678, 2010.
44. Furumoto Y, Brooks S, Olivera A, et al: Cutting Edge: lentiviral short hairpin RNA silencing of PTEN in human mast cells reveals constitutive signals that promote cytokine secretion and cell survival. J Immunol 176: 5167-5171, 2006.
45. Wick MJ, Dong LQ, Riojas RA, et al: Mechanism of phosphorylation of protein kinase B/Akt by a constitutively active 3-phosphoinositide-dependent protein kinase-1. J Biol Chem 275: 40400-40406, 2000. (Pubitemid 32064675)
46. Downward J: PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol 15: 177-182, 2004.
47. Casamayor A, Morrice NA and Alessi DR: Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo. Biochem J 342 (Pt 2): 287-292, 1999. (Pubitemid 29425348)
48. Sorenson CM, Padanilam BJ and Hammerman MR: Abnormal postpartum renal development and cystogenesis in the bcl-2 (-/-) mouse. Am J Physiol 271: F184-F193, 1996.
49. Sorenson CM, Rogers SA, Korsmeyer SJ and Hammerman MR: Fulminant metanephric apoptosis and abnormal kidney development in bcl-2-deficient mice. Am J Physiol 268: F73-F81, 1995. (Pubitemid 124005462)
50. Chandler D, el-Naggar AK, Brisbay S, et al: Apoptosis and expression of the bcl-2 proto-oncogene in the fetal and adult human kidney: evidence for the contribution of bcl-2 expression to renal carcinogenesis. Hum Pathol 25: 789-796, 1994. (Pubitemid 24249237)